Cargando…

AEs after homologous versus heterologous COVID-19 booster

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184392/
http://dx.doi.org/10.1007/s40278-022-16840-1
_version_ 1784724505648693248
collection PubMed
description
format Online
Article
Text
id pubmed-9184392
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91843922022-06-10 AEs after homologous versus heterologous COVID-19 booster Reactions Weekly Clinical Study Springer International Publishing 2022-06-11 2022 /pmc/articles/PMC9184392/ http://dx.doi.org/10.1007/s40278-022-16840-1 Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
AEs after homologous versus heterologous COVID-19 booster
title AEs after homologous versus heterologous COVID-19 booster
title_full AEs after homologous versus heterologous COVID-19 booster
title_fullStr AEs after homologous versus heterologous COVID-19 booster
title_full_unstemmed AEs after homologous versus heterologous COVID-19 booster
title_short AEs after homologous versus heterologous COVID-19 booster
title_sort aes after homologous versus heterologous covid-19 booster
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184392/
http://dx.doi.org/10.1007/s40278-022-16840-1